Country: Сједињене Америчке Државе
Језик: Енглески
Извор: NLM (National Library of Medicine)
HYDROQUINONE (UNII: XV74C1N1AE) (HYDROQUINONE - UNII:XV74C1N1AE)
OMP, INC.
HYDROQUINONE
HYDROQUINONE 40 mg in 1 g
PRESCRIPTION DRUG
The gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. Prior history of sensitivity or allergic reaction to this product or any of its ingredients. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.
Obagi Condition and Enhance Blender is available as follows: Obagi Condition and Enhance Clear is available as follows: Store at 25°C (77°F); excursion permitted to 15°C-30°C (59°F-86°F).
unapproved drug other
CONDITION AND ENHANCE SYSTEM TRAVEL-SIZE SURGICAL- HYDROQUINONE, OCTINOXATE AND ZINC OXIDE OMP, INC. _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- OBAGI CONDITION & ENHANCE CLEAR (HYDROQUINONE USP, 4%) SKIN BLEACHING CREAM OBAGI CONDITION & ENHANCE BLENDER (HYDROQUINONE USP, 4%) SKIN BLEACHING CREAM RX ONLY FOR EXTERNAL USE ONLY DESCRIPTION Hydroquinone is 1,4-benzenediol. Hydroquinone occurs as fine, white needles. The drug is freely soluble in water and in alcohol. Chemically, hydroquinone is designated as p-dihydroxybenzene; the empirical formula is C H O ; molecular weight is 110.0. OBAGI CONDITION & ENHANCE BLENDER contains Hydroquinone USP 40 mg/gm in a base of purified water, glycerin, cetyl alcohol, PPG-2 myristyl ether propionate, sodium lauryl sulfate, TEA-salicylate, lactic acid, phenyl trimethicone, tocopheryl acetate, sodium metabisulfite, ascorbic acid, methylparaben, saponins, disodium EDTA, BHT, and propylparaben. OBAGI CONDITION & ENHANCE CLEAR contains Hydroquinone USP 40 mg/gm in a base of purified water, cetyl alcohol, glycerin, sodium lauryl sulfate, stearyl alcohol, tocopheryl acetate, ascorbic acid, sodium metabisulfite, lactic acid, saponins, disodium EDTA, methylparaben, BHT, propylparaben, and butylparaben. CLINICAL PHARMACOLOGY Topical application of hydroquinone produces a reversible depigmentation of the skin by inhibition of the enzymatic oxidation of tyrosine to 3, 4-dihydroxyphenylalanine (dopa) and suppression of other melanocyte metabolic processes. Exposure to sunlight or ultraviolet light will cause repigmentation of the bleached areas, which may be prevented by the use of sunblocking agents or sunscreen agents contained in Obagi Condition & Enhance. ® ® ® 6 6 2 ® ® INDICATIONS AND USAGE The gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of Прочитајте комплетан документ